3,0
12 ago 2024
Dipendente attuale, più di 8 anni
Holzkirchen
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
- Great home office policy, good pay, canteen
Svantaggi
- Company is struggling to find its on way after the Spin off from Novartis - Lots of budget cuts and headcount reducation at the moment - Hard to move on the career ladder